Literature DB >> 34541043

Construction of a Highly Diverse mRNA Library for in vitro Selection of Monobodies.

Taishi Kondo1, Minori Eguchi1, Nariaki Tsuzuki1, Naoya Murata1, Tomoshige Fujino1, Gosuke Hayashi1,2, Hiroshi Murakami1,3.   

Abstract

Recently, we developed transcription/translation coupled with the association of puromycin linker (TRAP) display as a quick in vitro selection method to obtain antibody-like proteins. For the in vitro selection, it is important to prepare mRNA libraries among which the diversity is high. Here, we describe a method for the preparation of monobody mRNA libraries with greater than 1013 theoretical diversity. First, we synthesized two long single-stranded DNAs that corresponded to fragments of monobody DNA, with random codons in the BC and FG loops. These oligonucleotides were ligated by T4 DNA ligase with the support of guide oligonucleotides containing 3' ends that were protected by a modification. After amplifying the product DNAs by PCR, one end of each DNA fragment was digested with the type II restriction enzyme BsaI, and the resulting DNA fragments were ligated using T4 DNA ligase. After amplification of the DNA product, mRNAs were synthesized by T7 RNA polymerase. This method is simple and could be used for the preparation of mRNA libraries for various antibody-like proteins. Graphic abstract: Construction of a highly diverse mRNA library.
Copyright © 2021 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Antibody-like protein; In vitro selection ; Monobody; TRAP display; mRNA library

Year:  2021        PMID: 34541043      PMCID: PMC8413553          DOI: 10.21769/BioProtoc.4125

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  24 in total

1.  A novel strategy to engineer DNA polymerases for enhanced processivity and improved performance in vitro.

Authors:  Yan Wang; Dennis E Prosen; Li Mei; John C Sullivan; Michael Finney; Peter B Vander Horn
Journal:  Nucleic Acids Res       Date:  2004-02-18       Impact factor: 16.971

2.  mRNA display selection of a high-affinity, modification-specific phospho-IkappaBalpha-binding fibronectin.

Authors:  C Anders Olson; Hsiang-I Liao; Ren Sun; Richard W Roberts
Journal:  ACS Chem Biol       Date:  2008-07-01       Impact factor: 5.100

3.  The fibronectin type III domain as a scaffold for novel binding proteins.

Authors:  A Koide; C W Bailey; X Huang; S Koide
Journal:  J Mol Biol       Date:  1998-12-11       Impact factor: 5.469

4.  RNA-peptide fusions for the in vitro selection of peptides and proteins.

Authors:  R W Roberts; J W Szostak
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold.

Authors:  G Beste; F S Schmidt; T Stibora; A Skerra
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  Teaching an old scaffold new tricks: monobodies constructed using alternative surfaces of the FN3 scaffold.

Authors:  Akiko Koide; John Wojcik; Ryan N Gilbreth; Robert J Hoey; Shohei Koide
Journal:  J Mol Biol       Date:  2011-12-16       Impact factor: 5.469

7.  Facile generation of heat-stable antiviral and antitoxin single domain antibodies from a semisynthetic llama library.

Authors:  Ellen R Goldman; George P Anderson; Jinny L Liu; James B Delehanty; Laura J Sherwood; Lisa E Osborn; Larry B Cummins; Andrew Hayhurst
Journal:  Anal Chem       Date:  2006-12-15       Impact factor: 6.986

8.  In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells.

Authors:  Takashi Kawakami; Takahiro Ishizawa; Tomoshige Fujino; Patrick C Reid; Hiroaki Suga; Hiroshi Murakami
Journal:  ACS Chem Biol       Date:  2013-04-02       Impact factor: 5.100

Review 9.  Nanobodies: Chemical Functionalization Strategies and Intracellular Applications.

Authors:  Dominik Schumacher; Jonas Helma; Anselm F L Schneider; Heinrich Leonhardt; Christian P R Hackenberger
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-26       Impact factor: 15.336

10.  Antibody-like proteins that capture and neutralize SARS-CoV-2.

Authors:  T Kondo; Y Iwatani; K Matsuoka; T Fujino; S Umemoto; Y Yokomaku; K Ishizaki; S Kito; T Sezaki; G Hayashi; H Murakami
Journal:  Sci Adv       Date:  2020-10-14       Impact factor: 14.136

View more
  1 in total

1.  Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern.

Authors:  Taishi Kondo; Kazuhiro Matsuoka; Shun Umemoto; Tomoshige Fujino; Gosuke Hayashi; Yasumasa Iwatani; Hiroshi Murakami
Journal:  Life Sci Alliance       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.